Nanjing Qingpu

Nanjing Qingpu is a biotech company in Nanjing, China, founded in 2017. It has raised $100.7M across 3 rounds, most recently an $89.0M Series C in July 2026.

A Global Leader in Pain Management Drug Innovation

Headquarters
Nanjing
Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$100.7M
Last Round
$89.0M Series CJul 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Nanjing Delova Biotech (Nanjing Qingpu Biotechnology) is a 2017 Nanjing-based biopharmaceutical company that develops non-addictive, non-opioid drugs for unmet pain-management needs. It has built proprietary long-acting injectable platforms that can sustain drug release for days, weeks, or months, and a team spanning discovery through commercialization. In April 2025 its Putanning / QAMZOVA meloxicam injection was approved in both China and the United States, the first Chinese analgesic new drug to receive FDA marketing authorization. Delova also has more than ten novel non-opioid pipeline candidates, including QP002, QP-6211, and QP-5113.

Summary

It lists 51–200 employees. It has raised $100.7M in total across 3 rounds, most recently a $89.0M Series C round in Jul 2026. Investors include Partners Investment.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CJul 2026
$89.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nanjing Qingpu on Indexed.vc
<a href="https://indexed.vc/companies/nanjing-qingpu"><img src="https://indexed.vc/api/badge/company/nanjing-qingpu" alt="Nanjing Qingpu on Indexed.vc" width="260" height="76" /></a>